Literature DB >> 16282489

Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38.

Wen Dong1, Ulrich Kloz, Rosita Accardi, Sandra Caldeira, Wei-Min Tong, Zhao-Qi Wang, Lars Jansen, Matthias Dürst, Bakary S Sylla, Lutz Gissmann, Massimo Tommasino.   

Abstract

The oncoproteins E6 and E7 of human papillomavirus type 38 (HPV38) display several transforming activities in vitro, including immortalization of primary human keratinocytes. To evaluate the oncogenic activities of the viral proteins in an in vivo model, we generated transgenic mice expressing HPV38 E6 and E7 under the control of the bovine homologue of the human keratin 10 (K10) promoter. Two distinct lines of HPV38 E6/E7-expressing transgenic mice that express the viral genes at different levels were obtained. In both lines, HPV38 E6 and E7 induced cellular proliferation, hyperplasia, and dysplasia in the epidermis. The rate of occurrence of these events was proportional to the levels of HPV38 E6 and E7 expression in the two transgenic lines. Exposure of the epidermis of nontransgenic mice to UV led to p21WAF1 accumulation and cell cycle arrest. In contrast, keratinocytes from transgenic mice continued to proliferate and were not positive for p21WAF1, indicating that cell cycle checkpoints are altered in keratinocytes expressing the viral genes. Although the HPV38 E6/E7-expressing transgenic mice did not develop spontaneous tumors during their life span, two-stage carcinogen treatment led to a high incidence of papillomas, keratoacanthomas, and squamous-cell carcinomas in HPV38 mice compared with nontransgenic animals. Together, these data show that HPV38 E6 and E7 display transforming properties in vivo, providing further support for the role of HPV38 in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282489      PMCID: PMC1287566          DOI: 10.1128/JVI.79.23.14899-14908.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

Review 1.  The human papillomavirus E6 protein and its contribution to malignant progression.

Authors:  F Mantovani; L Banks
Journal:  Oncogene       Date:  2001-11-26       Impact factor: 9.867

Review 2.  Biological activities and molecular targets of the human papillomavirus E7 oncoprotein.

Authors:  K Münger; J R Basile; S Duensing; A Eichten; S L Gonzalez; M Grace; V L Zacny
Journal:  Oncogene       Date:  2001-11-26       Impact factor: 9.867

3.  Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis.

Authors:  S Song; A Liem; J A Miller; P F Lambert
Journal:  Virology       Date:  2000-02-15       Impact factor: 3.616

4.  Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins.

Authors:  S Jackson; C Harwood; M Thomas; L Banks; A Storey
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

Review 5.  Papillomaviruses and cancer: from basic studies to clinical application.

Authors:  Harald zur Hausen
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

6.  Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers.

Authors:  Soenke Jan Weissenborn; Ingo Nindl; Karin Purdie; Catherine Harwood; Charlotte Proby; Judy Breuer; Slawomir Majewski; Herbert Pfister; Ulrike Wieland
Journal:  J Invest Dermatol       Date:  2005-07       Impact factor: 8.551

Review 7.  Transgenic animal models of human papillomavirus-dependent disease (Review).

Authors:  R L Eckert; J F Crish; S Balasubramanian; E A Rorke
Journal:  Int J Oncol       Date:  2000-05       Impact factor: 5.650

8.  Identification of a novel activity of human papillomavirus type 16 E6 protein in deregulating the G1/S transition.

Authors:  Ilaria Malanchi; Sandra Caldeira; Maja Krützfeldt; Marianna Giarre; Marianna Alunni-Fabbroni; Massimo Tommasino
Journal:  Oncogene       Date:  2002-08-22       Impact factor: 9.867

9.  Deamination of 5-methylcytosines within cyclobutane pyrimidine dimers is an important component of UVB mutagenesis.

Authors:  Dong-Hyun Lee; Gerd P Pfeifer
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

10.  The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties.

Authors:  Sandra Caldeira; Ingeborg Zehbe; Rosita Accardi; Ilaria Malanchi; Wen Dong; Marianna Giarrè; Ethel-Michele de Villiers; Raffaele Filotico; Petra Boukamp; Massimo Tommasino
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more
  22 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice.

Authors:  Angelika Michel; Annette Kopp-Schneider; Hanswalter Zentgraf; Achim D Gruber; Ethel-Michele de Villiers
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

3.  Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73.

Authors:  Rosita Accardi; Wen Dong; Anouk Smet; Rutao Cui; Agnes Hautefeuille; Anne-Sophie Gabet; Bakary S Sylla; Lutz Gissmann; Pierre Hainaut; Massimo Tommasino
Journal:  EMBO Rep       Date:  2006-01-06       Impact factor: 8.807

Review 4.  The unexpected roles of eukaryotic translation elongation factors in RNA virus replication and pathogenesis.

Authors:  Dongsheng Li; Ting Wei; Catherine M Abbott; David Harrich
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

5.  Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin.

Authors:  Michelle R Iannacone; Tarik Gheit; Tim Waterboer; Anna R Giuliano; Jane L Messina; Neil A Fenske; Basil S Cherpelis; Vernon K Sondak; Richard G Roetzheim; Kristina M Michael; Massimo Tommasino; Michael Pawlita; Dana E Rollison
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-15       Impact factor: 4.254

6.  Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters.

Authors:  Djamel Saidj; Marie-Pierre Cros; Hector Hernandez-Vargas; Francesca Guarino; Bakary S Sylla; Massimo Tommasino; Rosita Accardi
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

7.  Proteomic analysis of the gamma human papillomavirus type 197 E6 and E7 associated cellular proteins.

Authors:  Miranda Grace; Karl Munger
Journal:  Virology       Date:  2016-10-20       Impact factor: 3.616

8.  NF-kappaB protects human papillomavirus type 38 E6/E7-immortalized human keratinocytes against tumor necrosis factor alpha and UV-mediated apoptosis.

Authors:  Ishraq Hussain; Ikbal Fathallah; Rosita Accardi; Jiping Yue; Djamel Saidj; Ruchi Shukla; Uzma Hasan; Tarik Gheit; Yamei Niu; Massimo Tommasino; Bakary S Sylla
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

9.  Cutaneous human papillomavirus type 38 E7 regulates actin cytoskeleton structure for increasing cell proliferation through CK2 and the eukaryotic elongation factor 1A.

Authors:  Jiping Yue; Ruchi Shukla; Rosita Accardi; Isabelle Zanella-Cleon; Maha Siouda; Marie-Pierre Cros; Vladimir Krutovskikh; Ishraq Hussain; Yamei Niu; Shiqiong Hu; Michel Becchi; Pierre Jurdic; Massimo Tommasino; Bakary S Sylla
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

Review 10.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.